NOS2 and colitis: For example, it has been reported that oral angiotensin II type 1 blockers and telmisartan administration inhibit ROS production by suppressing NF-κB, cyclooxygenase (COX) 2, and inducible nitric oxide synthase (iNOS) expression in a rat model of colitis [18].